About the Brain Cancer Awareness 5K
The second annual Brain Cancer Awareness 5K Run/Walk will take place on Saturday, August 22, at White Oak Park. Proceeds from the event will support brain cancer research at the University of Pittsburgh Cancer Institute.
The event is made possible by generous sponsors and those who have been brought together through shared experiences to raise funds.
Pre-register online for the Brain Cancer Awareness 5K to help fund cancer research. The cost is $30 per participant.
On-site registration will begin at 7:30 a.m. at the Redwood Pavilion, which is located at the very end of White Oak Park. Runners will begin their race at 9:00, and walkers will take off at 9:10.
Participants will be grouped according to age, and prizes will be awarded to the top finishers in each category.
Try to arrive as early as you can to ensure you get the correct T-shirt size and a parking spot near the Pavilion. Walk-up registration will be accepted, but T-shirts are not guaranteed for anyone who does not register online prior to the 5K.
Volunteers will shuttle runners and walkers from the overflow parking areas to the Redwood Pavilion, and handicapped spots will be saved for those who need one.
If you are unable to participate in the Brain Cancer Awareness 5K but would still like to donate, please visit the Fundraising Campaign page. You may also mail a check, made out to Brain Cancer Awareness 5K Limited, to Lois Basl, 44 Foxglove Drive, Greensburg, PA 15601.
Volunteers are still needed to make the event a success. If you would like to volunteer in any capacity, please email firstname.lastname@example.org or email@example.com.
About the University of Pittsburgh Cancer Institute
The University of Pittsburgh Cancer Institute (UPCI) was founded in 1985. UPCI is the only National Cancer Institute-designated Comprehensive Cancer Center in western Pennsylvania, which means the facility has demonstrated expertise in laboratory, clinical, and behavioral and population-based research. It is ranked among the top 10 cancer centers in the nation.
More than 400 research and clinical staff members translate promising lab studies into clinical trials to provide patients with new and innovative treatments. There are currently hundreds of ongoing clinical trials at UPCI and its partner, UPMC CancerCenter.
By recruiting internationally renowned scientists who develop prevention and early detection strategies and by providing survivorship and end-of-life care, UPCI maintains a comprehensive approach to understanding cancer.